RecruitingNCT05871762

Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer

Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer-a National Multi-center, Prospective, Real World Study

Sponsor

Peking Union Medical College Hospital

Enrollment

3,705 participants

Start Date

Jun 4, 2023

Study Type

OBSERVATIONAL

Conditions

Rectal Neoplasms

Summary

The purpose of this study is to compare the efficacy, prognosis, health economics of different treatment modalities of mid-low rectal cancer in different centers in China, and to conduct cost utility analysis (CUA) on the treatment process of rectal cancer to explore the best treatment modality that meets the actual need of medical units in each region and at each level. The investigators hope to provide evidence-based medical suggestions for medical quality control of rectal cancer and revision of clinical guidelines, and provides a source of decision making for medical management and medical insurance.

Eligibility

Plain Language Summary

Simplified for easier understanding

This study is comparing different treatment strategies for mid to low rectal cancer — cancer in the lower part of the large bowel — to find the most effective approach in terms of outcomes and quality of life. **You may be eligible if...** - You have been diagnosed with rectal adenocarcinoma (confirmed by pathology) - Your cancer is located within 12 cm of the anal opening **You may NOT be eligible if...** - Your cancer has already spread to other parts of the body (distant metastases) - You have multiple primary colorectal cancers at the same time - You have had a previous cancer diagnosis - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.